Evommune, Inc.
EVMN
$14.65
$0.584.12%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.25M | -21.67M | -28.27M | -12.48M | -13.57M |
| Total Depreciation and Amortization | 552.00K | 349.00K | 326.00K | 311.00K | 375.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.84M | 2.66M | 3.61M | 49.00K | -8.75M |
| Change in Net Operating Assets | 7.54M | -8.84M | 7.64M | 2.48M | -4.27M |
| Cash from Operations | -20.32M | -27.50M | -16.70M | -9.64M | -26.21M |
| Capital Expenditure | -183.00K | -83.00K | -104.00K | -131.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.48M | -85.28M | -122.80M | -23.78M | 18.00M |
| Cash from Investing | 31.29M | -85.36M | -122.90M | -23.91M | 18.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -142.00K | -87.00K | -86.00K | -136.00K | -155.00K |
| Issuance of Common Stock | 674.00K | 117.20M | 157.28M | 0.00 | 4.00K |
| Repurchase of Common Stock | -- | -- | -1.22M | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 65.23M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 874.00K | -138.00K | -736.00K |
| Cash from Financing | 532.00K | 117.11M | 156.85M | -274.00K | 64.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.51M | 4.25M | 17.25M | -33.82M | 56.13M |